Literature DB >> 2897273

Histamine H2 receptor antagonists and blood alcohol levels.

G Holtmann, M V Singer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2897273     DOI： 10.1007/bf01540445

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  Cimetidine inhibits microsomal drug metabolism in the rat.

Authors:  J Puurunen; O Pelkonen
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

2.  Interaction of cimetidine with liver microsomes.

Authors:  S Rendić; V Sunjić; R Toso; F Kajfez; H H Ruf
Journal:  Xenobiotica       Date:  1979-09       Impact factor: 1.908

3.  Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses?

Authors:  G Dobrilla; G de Pretis; L Piazzi; F Chilovi; M Comberlato; M Valentini; A Pastorino; P Vallaperta
Journal:  Hepatogastroenterology       Date:  1984-02

4.  Effects of cimetidine on the elimination and actions of ethanol.

Authors:  J Feely; A J Wood
Journal:  JAMA       Date:  1982-05-28       Impact factor: 56.272

5.  In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats.

Authors:  H K Seitz; S Veith; P Czygan; J Bösche; B Simon; R Gugler; B Kommerell
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

6.  [The effect of cimetidine on the metabolism and effects of alcohol].

Authors:  K I Johnson; E Fenzl; B Hein
Journal:  Arzneimittelforschung       Date:  1984
  6 in total
  3 in total

Review 1.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

2.  Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Authors:  A S Brown; J R Fiaterone; C P Day; M K Bennett; P J Kelly; O F James
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 3.  Clinical pharmacokinetics of famotidine.

Authors:  H Echizen; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.